多功能,模块化组织工程贴片与ECM和合成粘合剂,用于无的胃肠道缺陷修复
Linqiang Wu1, Qi He2, Hao Zheng1
1School of Life Science and Technologies, ShanghaiTech University, Shanghai, 201210, China.
Acta biomaterialia
|March 13, 2026
概括
一种新的组织工程胃肠道补丁 (TEGIP) 为胃肠道缺陷提供了无的解决方案. 这种多功能贴片有效地密封穿孔,减少粘附,并促进组织修复,增强生物相容性.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 胃肠病学 胃肠病学
背景情况:
- 胃肠壁缺陷带来了重大的临床挑战,包括泄漏,感染和粘附.
- 目前的合成贴片往往具有较差的生物相容性,导致炎症和组织整合不足.
研究的目的:
- 开发和评估一种多功能组织工程胃肠贴片 (TEGIP),用于无地修复胃肠道缺陷.
- 通过提高生物相容性和减少术后粘附来解决现有合成贴片的局限性.
主要方法:
- 使用非细胞皮肤基质 (ADM),甲基烯酸氨酸 (HAMA) 水凝和聚乙烯胺/聚烯酸 (PEI/PAA) 粘合剂构建了一个三层TEGIP.
- 进行了体外机械测试,细胞粘附测试和爆破压力测量.
- 在体内评估中使用了老鼠急性胃穿孔模型来评估密封功效,粘附减少和组织反应.
主要成果:
- TEGIP 显示出强大的机械耐用性 (11.6 ± 2.0 MPa) 和高爆压 (155 ± 22 mmHg),用于密封 10 毫米孔径.
- 哈马层有效地减少了细胞粘附,而PEI/PAA粘合剂的粘合强度与纤维素相美.
- 在体内研究表明有效的缺陷密封,显著减少术后粘附,并有潜在的引导组织修复没有观察到肝毒性.
结论:
- 三层TEGIP为胃肠道缺陷修复提供了一个有前途的无解决方案.
- 它提供强大的密封,增强生物相容性,并减轻粘附相关的并发症.
- TEGIP促进了组织修复,并证明了持续的生物相容性,将其定位为胃肠道外科手术的进步.
更多相关视频
20:33A Case Series of Successful Abdominal Closure Utilizing a Novel Technique Combining a Mechanical Closure System with a Biologic Xenograft that Accelerates Wound Healing
Published on: July 4, 2019
52.2K
08:56Tissue-Engineered Graft for Circumferential Esophageal Reconstruction in Rats
Published on: February 10, 2020
7.7K
相关概念视频
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
Endoscopic Procedures V: ERCP
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
Patient...
